ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kentucky » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Kentucky

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MELECIO ABORDO M.D.

Cardiovascular Disease

35,558

$1.83M

1235
754 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

23%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $58

CHARLES RHODES M.D.

Cardiovascular Disease

19,114

$1.42M

849
714 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$74
Average prescription price

Avg: $58

VICENTE KAW MD

Cardiovascular Disease

18,521

$882K

406
333 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

24%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $58

NATARAJAN THANNOLI MD

Cardiovascular Disease

15,503

$1.17M

1230
950 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 23%

$75
Average prescription price

Avg: $58

STEPHEN BOYER M.D.

Cardiovascular Disease

14,131

$945K

1002
891 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $58

WILLAM SKINNER MD

Cardiovascular Disease

14,091

$854K

1129
902 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $58

ERIC LOHMAN MD

Cardiovascular Disease

13,701

$711K

850
633 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $58

KHALID CHAUDRY M.D.

Cardiovascular Disease

13,503

$1.03M

548
426 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

19%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$76
Average prescription price

Avg: $58

CHRISTODULOS STAVENS M.D.

Cardiovascular Disease

13,497

$763K

1005
779 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $58

VIDYA YALAMANCHI M.D.

Cardiovascular Disease

12,740

$471K

1220
837 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 23%

$37
Average prescription price

Avg: $58

DALE SENIOR MD

Cardiovascular Disease

11,690

$563K

732
610 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $58

KEVIN SCULLY M.D.

Cardiovascular Disease

11,669

$816K

765
668 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 23%

$70
Average prescription price

Avg: $58

ANIS CHALHOUB M.D.

Cardiovascular Disease

11,375

$644K

464
287 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $58

ARUN UMMAT M.D.

Cardiovascular Disease

11,081

$529K

824
689 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $58

JOHN AUMILLER MD

Cardiovascular Disease

10,996

$607K

939
778 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $58

ROBERT HAMMONS MD

Cardiovascular Disease

10,729

$792K

545
462 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 23%

$74
Average prescription price

Avg: $58

DEEPAK KAPADIA MD

Cardiovascular Disease

10,652

$740K

919
676 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 23%

$69
Average prescription price

Avg: $58

DAVID SIHAU MD

Cardiovascular Disease

10,527

$848K

616
520 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 23%

$81
Average prescription price

Avg: $58

ASHWINI ANAND M.D.

Cardiovascular Disease

10,050

$491K

799
484 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $58

JOHN THOMAS MD

Cardiovascular Disease

10,016

$588K

918
780 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $58

DAVID KEEDY M.D.

Cardiovascular Disease

9,965

$582K

645
527 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $58

JOHNNY MAKHOUL MD

Cardiovascular Disease

9,245

$383K

748
641 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 23%

$41
Average prescription price

Avg: $58

SRIHARSHA VELURY MD

Cardiovascular Disease

9,154

$579K

951
606 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $58

RICHARD GROVER MD

Cardiovascular Disease

8,763

$431K

561
520 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $58

SRIDHAR BANURU MD

Cardiovascular Disease

8,712

$515K

835
657 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank